These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...
US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...
The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...